Human melanoma cells secrete and respond to placenta growth factor and vascular endothelial growth factor

Journal of Investigative Dermatology

Volumn 115, Issue 6, 2000, Pages 1000-1007

  Lacal, Pedro M ^a   Failla, Cristina M ^b   Pagani, Elena ^a   Odorisio, Teresa ^b   Schietroma, Cataldo ^b   Falcinelli, Sabrina ^a   Zambruno, Giovanna ^b   D'Atri, Stefania ^a  

^a Ist Superiore San Viale Regina E   (Italy)

^b LABORATORIO DI PATOLOGIA VASCOLARE   (Italy)

Author keywords

Angiogenesis; Melanoma progression

Indexed keywords

MESSENGER RNA; NEUROPILIN; PLACENTAL GROWTH FACTOR; UNCLASSIFIED DRUG; VASCULOTROPIN; VASCULOTROPIN RECEPTOR;

ANGIOGENESIS; ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; MELANOMA; MELANOMA CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SKIN METASTASIS; TUMOR GROWTH;

EID: 0034518226     PISSN: 0022202X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1747.2000.00199.x     Document Type: Article

References (51)

1. HMEC-1: Establishment of an immortalized human microvascular endothelial cell line
2. VEGF, VEGF-B, VEGF-C and their receptors KDR, Flt-1 and Flt-4 during the neoplastic progression of human colonic mucosa
3. Human keratinocytes express the three major splice forms of vascular endothelial growth factor
4. Migration of human monocytes in response to vascular endothelial growth factor (VEGF) is mediated via the VEGF receptor flt-1
5. Expression of vascular endothelial growth factor and its receptors flt-1 and KDR in ovarian carcinoma
6. Heterodimers of placenta growth factor/vascular endothelial growth factor
7. In vivo angiogenic activity and hypoxia induction of heterodimers of placenta growth factor/vascular endothelial growth factor
8. Placenta growth factor: Identification and characterization of a novel isoform generated by RNA alternative splicing
9. Comparison of expression patterns for placenta growth factor, vascular endothelial growth factor (VEGF), VEGF-B and VEGF-C in the human placenta throughout gestation
10. The vascular endothelial growth factor receptor Flt-1 mediates biological activities
11. VEGF121, a vascular endothelial growth factor (VEGF) isoform lacking heparin binding ability, requires cell-surface heparan sulfates for efficient binding to the VEGF receptors of human melanoma cells
12. Expression of cytokine genes, including IL-6, in human malignant melanoma cell lines
13. Human epithelial cells induce human melanocyte growth in vitro but only skin keratynocytes regulate its proper differentiation in the absence of dermis
14. The possible role of angiogenesis in the metastatic potential of human melanoma. Clinicopathological aspects
15. Purification and characterization of a naturally occurring vascular endothelial growth factor/placenta growth factor heterodimer
16. Expression and localization of placenta growth factor and PlGF receptors in human meningiomas
17. Tumors: Wounds that do not heal. Similarities between tumor stroma generation and wound healing
18. Reverse transcriptio-polymerase chain reaction products of alternatively spliced mRNAs form DNA heteroduplexes and heteroduplex complex
19. Transition of horizontal to vertical growth phase melanoma is accompanied by induction of vascular endothelial growth factor expression and angiogenesis
20. Placenta growth factor is induced in human keratinocytes during wound healing
21. The role of vascular endothelial growth factor in pathological angiogenesis
22. Expression of vascular endothelial growth factor receptors in human prostate cancer
23. Angiogenesis in cancer, vascular, rheumatoid and other disease
24. Prognostic and predictive value of intra-tumoral microvessel densiy in human solid tumours
25. Human melanoma cells but not normal melanocytes express vascular endothelial growth factor receptors
26. Neuropilin-2 and neuropilin-1 are receptors for VEGF165 and PlGF-2, but only neuropilin-2 functions as a receptor for VEGF145
27. Comparison of histocompatibility antigens on cultured human tumor cells and fibroblasts by quantitative antibody absorption and sensitivity to cell-mediated cytotoxicity
28. Melanoma-associated expression of vascular endothelial growth factor and its receptors Flt-1 and KDR
29. Inhibition of vascular endothelial cell growth factor activity by an endogenously encoded soluble receptor
30. Placenta growth factor is abundantly expressed in human cervical squamous cell carcinoma
31. Placenta growth factor stimulates MAP kinase and mitogenicity but not phospholipase C-γ and migration of endothelial cells expressing Flt-1
32. Melanoma cell lines express VEGF receptor KDR and respond to exogenously added VEGF
33. Isolation of a human placenta cDNA coding for a protein related to vascular permeability factor
34. Two alternative mRNAs coding for the angiogenic factor, placenta growth factor (PlGF), are transcribed from a single gene of chromosome 14
35. Angiogenesis and malignant melanoma. Angiogenesis is related to the development of vertical (tumorigenic) growth phase
36. Vascular endothelial growth factor/vascular permeability factor is an autocrine growth factor for AIDS-Kaposi sarcoma
37. Neuropilin-1 is a placenta growth factor-2 receptor
38. High affinity VEGF binding and developmental expression suggest Flk-1 as a major regulator of vasculogenesis and angiogenesis
39. Vascular endothelial growth factor (VEGF) and its receptors
40. VEGF145, a secreted vascular endothelial growth factor isoform that binds to extracellular matrix
41. Enhanced expression of vascular endothelial growth factor in metastatic melanoma
42. Melanoma cell lines from different stages of progression and their biological and molecular analysis
43. Flt-1 but not KDR/Flk-1 tyrosine kinase is a receptor for placenta gowth factor, which is related to vascular endothelial growth factor
44. Cell surface antigens of human malignant melanoma. II. Serological typing with immune adherence assays and definition of two new surface antigens
45. Neuropilin-1 is expressed by endothelial and tumor cells as an isoform-specific receptor for vascular endothelial growth factor
46. Tumor-specific cytolysis by lymphocytes infiltrating human melanomas
47. Different signal transduction properties of KDR and Flt1, two receptors for vascular endothelial growth factor
48. Analysis of antigens recognized on human melanoma cells by A2-restricted cytolytic T lymphocytes (CTL)
49. Transforming growth factor-β1 modulates β1 and β5 integrin receptors and induces de novo expression of the αvβ6 heterodimer in normal human keratinocytes: Implications for wound healing
50. Placenta growth factor-1 is chemotactic, mitogenic, and angiogenic